Scispot

Emerging

Kitchener Canada YC "Snowflake for Biotech" LIMS/ELN/lab data infrastructure at $2.8M revenue 2024 (up from $1.7M); YC/Ontario Genomics/CDL-backed serving biotech companies with AI-ready lab data competing with Benchling.

Company Overview

About Scispot

Scispot is a Kitchener, Canada-based biotech data infrastructure platform — backed by Y Combinator with $600,000+ in funding from Y Combinator, Ontario Genomics, and Creative Destruction Lab — providing biotechnology companies and research laboratories with an integrated AI-driven laboratory management system (LIMS), electronic lab notebook (ELN), sample tracking, and regulatory compliance platform that transforms lab data into AI-ready infrastructure. Positioning as "Snowflake for Biotech," Scispot achieved $2.8 million in revenue in 2024 (up from $1.7 million in 2023) with 18 employees, serving customers including PERSIST.AI and Indee Labs with the comprehensive biotech data management stack needed to leverage AI for drug discovery and research acceleration.

Business Model & Competitive Advantage

Scispot's biotech data infrastructure platform addresses the data fragmentation problem that prevents life sciences companies from applying AI to their experimental data: a drug discovery company running 50 concurrent experiments generates data in spreadsheets, standalone LIMS databases, ELN systems, sequencing platform exports, and instrument vendor software — each in different formats, with different sample tracking metadata, stored in different locations without a unified data model. When a computational biologist tries to train an AI model on the company's historical experimental data to predict which compounds will show activity, they spend 80% of their time cleaning and normalizing data from 6 different systems. Scispot's unified platform (capturing experimental data from lab instruments, protocols, and workflows into a centralized, structured database with consistent metadata schemas and API access) creates the clean, queryable data foundation that AI-powered research requires.

Competitive Landscape 2025–2026

In 2025, Scispot competes in the biotech LIMS, electronic lab notebook, and laboratory informatics market with Benchling (biotech R&D platform, $200M raised at $6.1B valuation), Dotmatics (scientific software, acquired by Insightful Science), and LabArchives (ELN, acquired by Revvity) for biotech and pharma company laboratory data management and AI-ready scientific infrastructure platform adoption. Ontario Genomics' investment reflects Canadian biotech ecosystem support. Y Combinator backing connects Scispot with the biotech tools and life sciences SaaS investment community. The "Snowflake for Biotech" positioning (referencing Snowflake's $30B+ data cloud success) reflects ambition to become the data infrastructure layer for AI-driven drug discovery. The 2025 strategy focuses on the Series A stage biotech company (10-100 person labs generating significant experimental data), building the AI analysis layer for automated pattern recognition in experimental datasets, and expanding the regulatory compliance documentation for FDA 21 CFR Part 11 electronic records requirements.

Revenue
$2.8M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Scispot is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

AbbVie

Healthcare
AnalyticsB2bEnterpriseGlobalHealthtechPublic

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp

Yoneda Labs

Healthcare
HealthtechB2bNorth America

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit

Decoda Health

Healthcare
HealthtechAi PoweredAutomationNorth America

Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap

Fortuna Health

Healthcare
HealthtechB2bAi PoweredAutomationNorth America

Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Compare Scispot with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Scispot

Claim This Profile

Are you from Scispot? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Scispot Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Scispot vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →